Cargando…

History of hematopoietic cell transplantation: challenges and progress

After more than 60 years of research in allogeneic hematopoietic cell transplantation (HCT), this therapy has advanced from one that was declared dead in the 1960s to a standard treatment of otherwise fatal malignant and non-malignant blood diseases. To date, close to 1.5 million hematopoietic cell...

Descripción completa

Detalles Bibliográficos
Autores principales: Granot, Noa, Storb, Rainer
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Fondazione Ferrata Storti 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7716373/
https://www.ncbi.nlm.nih.gov/pubmed/33054108
http://dx.doi.org/10.3324/haematol.2019.245688
_version_ 1783619146546675712
author Granot, Noa
Storb, Rainer
author_facet Granot, Noa
Storb, Rainer
author_sort Granot, Noa
collection PubMed
description After more than 60 years of research in allogeneic hematopoietic cell transplantation (HCT), this therapy has advanced from one that was declared dead in the 1960s to a standard treatment of otherwise fatal malignant and non-malignant blood diseases. To date, close to 1.5 million hematopoietic cell transplants have been performed in more than 1,500 transplantation centers worldwide. This review will highlight the enormous efforts by numerous investigators throughout the world who have brought the experimental field of HCT to clinical reality, examine ongoing challenges, and provide insights for the future.
format Online
Article
Text
id pubmed-7716373
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Fondazione Ferrata Storti
record_format MEDLINE/PubMed
spelling pubmed-77163732020-12-10 History of hematopoietic cell transplantation: challenges and progress Granot, Noa Storb, Rainer Haematologica Centenary Review Article After more than 60 years of research in allogeneic hematopoietic cell transplantation (HCT), this therapy has advanced from one that was declared dead in the 1960s to a standard treatment of otherwise fatal malignant and non-malignant blood diseases. To date, close to 1.5 million hematopoietic cell transplants have been performed in more than 1,500 transplantation centers worldwide. This review will highlight the enormous efforts by numerous investigators throughout the world who have brought the experimental field of HCT to clinical reality, examine ongoing challenges, and provide insights for the future. Fondazione Ferrata Storti 2020-10-09 /pmc/articles/PMC7716373/ /pubmed/33054108 http://dx.doi.org/10.3324/haematol.2019.245688 Text en Copyright© 2020 Ferrata Storti Foundation http://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution Noncommercial License (by-nc 4.0) which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.
spellingShingle Centenary Review Article
Granot, Noa
Storb, Rainer
History of hematopoietic cell transplantation: challenges and progress
title History of hematopoietic cell transplantation: challenges and progress
title_full History of hematopoietic cell transplantation: challenges and progress
title_fullStr History of hematopoietic cell transplantation: challenges and progress
title_full_unstemmed History of hematopoietic cell transplantation: challenges and progress
title_short History of hematopoietic cell transplantation: challenges and progress
title_sort history of hematopoietic cell transplantation: challenges and progress
topic Centenary Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7716373/
https://www.ncbi.nlm.nih.gov/pubmed/33054108
http://dx.doi.org/10.3324/haematol.2019.245688
work_keys_str_mv AT granotnoa historyofhematopoieticcelltransplantationchallengesandprogress
AT storbrainer historyofhematopoieticcelltransplantationchallengesandprogress